Wolters Kluwer puts Adis on block
Wolters Kluwer said it will divest its Pharma Solutions business unit, in two parts.
Brands now on the block include the PHAST syndicated prescription data service, plus the Adis R&D Insight and inThought pipeline analysis tools.
Pharma Solutions “no longer fits with the [company] growth strategy,” which is to focus spending and investment in core healthcare provider markets, Robert Dekker, VP of communications for Wolters Kluwer Health & Pharma Solutions, told MM&M.
Health brands that are staying include the Lippincott Williams & Wilkins textbooks and journals, and UpToDate web and mobile medical apps.
Officials expect to close a sale around, or shortly after, year's end. William Blair & Co. and Lazard Middle Market have been retained as advisors for separate sell-offs of the healthcare analytics and marketing & publishing services businesses, respectively.